Lalit Kumar
Impact in
- Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Cancer Research top 2%
- MicroRNA in disease regulation
Papers in ⓘ
-
- Advanced Drug Delivery Systems 36
- Drug Solubulity and Delivery Systems 29
- Advancements in Transdermal Drug Delivery 28
- Hematology 54
- Multiple Myeloma Research and Treatments 26
- Co-authors
- Ruchi Verma (39 shared papers)Shubhrata Gupta (9 shared papers)Shivam Prakash Gautam (9 shared papers)Rupesh Kalidas Shirodkar (30 shared papers)Shamsuzzama Shamsuzzama (10 shared papers)Salwa (18 shared papers)Aamir Nazir (6 shared papers)Rizwanul Haque (5 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Hematology (7 papers)Journal of Drug Delivery Science and Technology (6 papers)European Journal of Medicinal Chemistry (5 papers)Journal of Pharmaceutical Innovation (5 papers)
- Partner nations
- IndiaUnited StatesAustralia
In The Last Decade
Lalit Kumar
393 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 199
- Pharmaceutical Science 803
- Cancer Research 685
- Hematology 476
- Genetics 323
- Oncology 727
Countries citing papers authored by Lalit Kumar
This map shows the geographic impact of Lalit Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalit Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalit Kumar more than expected).
Fields of papers citing papers by Lalit Kumar
This network shows the impact of papers produced by Lalit Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalit Kumar. The network helps show where Lalit Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Lalit Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 432 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 3D Printing as a Promising Tool in Personalized Medicine Hit paper breakdown → | 2021 | 277 |
| 2 | 2019 | 214 | |
| 3 | 2016 | 159 | |
| 4 | 2010 | 119 | |
| 5 | 2018 | 116 | |
| 6 | 2010 | 104 | |
| 7 | 2015 | 103 | |
| 8 | 2022 | 102 | |
| 9 | 1999 | 95 | |
| 10 | 2016 | 95 | |
| 11 | 2014 | 89 | |
| 12 | 1975 | 88 | |
| 13 | 2023 | 87 | |
| 14 | 2018 | 86 | |
| 15 | 2019 | 81 | |
| 16 | 2016 | 76 | |
| 17 | 2015 | 73 | |
| 18 | 2018 | 72 | |
| 19 | 2018 | 70 | |
| 20 | 2009 | 69 |
About Lalit Kumar
Lalit Kumar is a scholar working on Pharmaceutical Science, Hematology, Aging, Genetics and Analytical Chemistry, having authored 432 papers that have together received 6.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (44 papers), Advanced Drug Delivery Systems (36 papers), Analytical Methods in Pharmaceuticals (32 papers), Drug Solubulity and Delivery Systems (29 papers), Chronic Lymphocytic Leukemia Research (29 papers), Advancements in Transdermal Drug Delivery (28 papers), Multiple Myeloma Research and Treatments (26 papers) and Viral-associated cancers and disorders (23 papers). The work is most often cited by research in Pharmaceutical Science (803 citations), Cancer Research (685 citations), Hematology (476 citations), Genetics (323 citations) and Oncology (727 citations). Lalit Kumar has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Ruchi Verma, Shubhrata Gupta, Shivam Prakash Gautam, Rupesh Kalidas Shirodkar, Shamsuzzama Shamsuzzama, Salwa, Aamir Nazir, Rizwanul Haque, Atul Sharma and Ngawang Chhogyel. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, Journal of Drug Delivery Science and Technology, European Journal of Medicinal Chemistry and Journal of Pharmaceutical Innovation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.